BCAN is proud to offer patient insight webinars, bringing nationally recognized bladder cancer experts directly to patients and families to address important topics related to bladder cancer diagnosis, treatment, research and quality of life. A webinar is an event held on the internet which is attended exclusively by an online audience. BCAN brings leading bladder cancer experts in these free programs, directly to your phone, computer or tablet.
Please see below for information about upcoming webinars and to view past webinars. If you have any questions please contact us at firstname.lastname@example.org.
Bladder Cancer and the Brave: Occupational & Environmental Risks for the US Military
With Polly Hoppin, DSc, Matthew Mossanen, MD, MPH, and Richard Clapp, DSc.
The 6th most common cancer in America, bladder cancer affects many veterans across the United States. Find out what is known about occupational and environmental risk factors for Vietnam era veterans through modern warfare veterans and service members.
In 2016, the Institute of Medicine released information regarding possible health effects from exposure to Agent Orange and other herbicides used in Vietnam. Bladder cancer was moved from “inadequate or insufficient” evidence of association up to “limited or suggestive” evidence of association. The VA is currently in the process of considering whether to add bladder cancer to its list of presumptive conditions associated with Agent Orange exposure.
Individuals serving or living at the U.S. Marine Corps Base Camp LeJeune, North Carolina, were exposed to drinking water contaminated with industrial solvents, benzene, and other chemicals.
The VA Airborne Hazards and Open Burn Pit Registry allows eligible Veterans and service members to document their exposures and report health concerns.
Wednesday, November 13, 2019, 5-6 PM EST. Learn more and register here.
Shining a Light on Rare Forms of Bladder Cancer
With Dr. Andrea Apolo, MD
As the 6th most common cancer in the US, Bladder Cancer is not a rare disease. But within the scope of bladder cancer, there are rare variations that are more challenging to treat. Medical oncologist Dr. Andrea Apolo, Chief, of the Bladder Cancer Section Genitourinary Malignancies Branch at the National Cancer Institute (NCI) will address these unique challenges to treating patients who are diagnosed with these rarer forms of bladder cancer.
Tuesday, November 19, 2019, 5-6 PM EST. Learn more and register here.
What you should know about the care and keeping of your ileal conduit – A chat with the experts.
With Jocelyn Goffney, MSN RN CWOCN and BCAN Patient Advocates Anne & Darrell
An ileal conduit (IC) is the most common urinary diversion performed by urologists. It is a simple form of urinary tract reconstruction that uses the ileum (a small piece of the intestine) as an alternate pathway for urine to exit the body. The IC does not store urine. It is a way to remove urine from the body.
Thursday, December 12, 2019, 5-6 PM EST. Learn more and register here.
Bladder Cancer in Women – The Unspoken Demographic
With Dr. Sima Porten, MD, MPH and Dr. Jean Hoffman-Censits, MD
Bladder cancer has long been considered a disease of older men. Though it is more prevalent in men, studies have shown that women of any age and race, are more likely to present more advanced tumors and have a worse prognosis than men, at almost every stage of the disease. Watch this webinar, featuring medical oncologist Dr. Jean Hoffman-Censits of John’s Hopkins Medical and urologist Dr. Sima Porten of the University of California San Francisco.
Tuesday, December 17, 2019, 7-8 PM EST. Learn more and register here.